199 related articles for article (PubMed ID: 11509145)
1. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
Deng L; Zhou Y; Peng X; Deng H; Deng Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
3. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
[TBL] [Abstract][Full Text] [Related]
4. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
Xu GG; Luo CY; Wu SM; Wang CL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
[TBL] [Abstract][Full Text] [Related]
5. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
Zheng M; Cai W; Weng H; Liu R
Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
8. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
[TBL] [Abstract][Full Text] [Related]
9. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
Chen YP; Feng XR; Dai L; Ding HB; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
[TBL] [Abstract][Full Text] [Related]
10. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
12. [The detection and clinical significance of hepatic fibrosis index].
Xu CH; Meng DM; Lv SL; Kang P
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):50-2. PubMed ID: 20848851
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J
Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effect of alpha 1b interferon on patients with chronic hepatitis B: changes in serological fibrosis markers and histology].
Zhang HY; Lu H; Li XM; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):117-8. PubMed ID: 12648417
[No Abstract] [Full Text] [Related]
16. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C.
Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagasawa M; Toyama T; Ozaki S; Naito M; Azuma M
Hepatology; 1996 Jul; 24(1):27-31. PubMed ID: 8707274
[TBL] [Abstract][Full Text] [Related]
17. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
18. [Influence of interferon alpha on the serum fibrosis markers of chronic hepatitis C patients].
Zhang BB; Zhu SH; Cai WM
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):622-3. PubMed ID: 14572344
[No Abstract] [Full Text] [Related]
19. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological study on liver fibrosis in viral hepatitis].
Xin S; Mao Y; Wang L; Li Y; Li L; Yu H; Zhao M; Zhang S; Wang S; Wang X; Chen L; Zhou X; Zhou Y; Zou Z; Tang S; Huangpu Y; Zhang L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]